It has been reported that chemoradiotherapy increases the expression of galectin-9 and PD-L1 on the cell membrane in gastric cancer cell lines [123], and combination therapy in actual clinical practice is expected in the future. The gene discussed is LGALS9; the disease is gastric cancer.